Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC)

Abroad (travel likely)RecruitingPHASE1

Conditions

Bladder Cancer (BC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Contact: Study coordinator (Zheng Liu PhD) · lz2013tj@163.com · +86 13297997093
Contact: Principal Investigator (Zheng Liu, PhD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis

Urothelial Carcinoma (UC) · Upper Tract Urothelial Carcinoma · UTUC

Abroad (travel likely)Recruiting

Zhengzhou, China

Local Radiotherapy for Urinary Bladder Cancer in Patients Not Eligible for Curative Treatment

Bladder Cancer (BC)

Abroad (travel likely)Recruiting

Umeå, Sweden